Be proud, be loud, but don't annoy the crowd! Science communication is entering a new era, where it pays off to complement your standard poster with online outreach work. Altmetrics (media mentions, article views, tweets etc.) are becoming crucial. But don't be a show off!

Is use of low-dose methotrexate (MTX) associated with an increased risk of skin cancer? Please find the key findings from our 🇩🇰 case-control study in the 🧵below British Journal of Cancer Cancer Research UK Nature Portfolio Springer Nature doi.org/10.1038/s41416… #dermtwitter #MedTwitter #MedEd 👇🏻

Check out my PhD student Julia Fougelberg's study on dermoscopy in intraepidermal carcinoma, based on findings from international expert dermoscopists. Apart from scales and dotted/glomerular vessels, pinkish-white areas were the most common features. doi.org/10.5826/dpc.13…

Today’s #AMC2023 plenary session delivered to a packed auditorium. MIA's Professor Georgina Long AO (Bluesky @gvlongphdmd), @ProfRScolyerMIA & A/P Alexander van Akkooi presented 'Neoadjuvant Immunotherapy: A Game Changer’, followed by panel discussion incl consumer rep Karen van Gorp from Melanoma Australia ASSC

We need more prognostic factors for the large group of thin melanoma patients! Could the answer be found in spatial transcriptomics? Great talk by Dr Chenhao Zhou who has worked on our unique case-case series of thin melanomas. Chenhao Zhou Kiarash David Whiteman

Great job, Edwige, Bonnie and Kiarash!

ICYMI: Thin melanomas are responsible for almost a quarter of melanoma deaths so more understanding of which patients are at highest risk is required, researchers say. JEADV H. Peter Soyer David Whiteman Magdalena Claeson bit.ly/3q6rKsu

Interview on Swedish National Radio (Vaken i P3 och P4) about our new research on BRAF mutations in thin melanomas, and about the importance of sun protection and early diagnosis. (In Swedish, interview after 5.09.43) doi.org/10.1111/jdv.19… sverigesradio.se/avsnitt/2164136

Another manuscript just out in JEADV originating from my postdoc period in Brisbane. Thin melanomas are more deadly if they are BRAF-V600E neg, if they develop de novo, and if they have high mitotic activity! doi.org/10.1111/jdv.19… Kliniska vetenskaper Sahlgrenska Academy Sahlgrenska Universitetssjukhuset

Excellent presentation by doctoral student Alexandra Sjöholm at the half-time review of her studies, entitled "Simulatated Daylight Photodynamic Therapy for Superficial Skin Cancer". I, John Paoli and PhD Birgit Heckeman are happy supervisors! Kliniska vetenskaper, Sahlgrenska Universitetssjukhuset

What a treat!!! ...to hear our PhD student Julia Fougelberg deliver her thesis on intraepidermal carcinoma: 1) dermoscopic findings showed poor to moderate interobserver agreement, 2) 63% clearence after PDT, and 3) surgical inexperience is a risk factor for incomplete excision.

A really dynamic and fruitful meeting with the Swedish Melanoma Study Group (SMSG) in stormy and cold Vadstena, the cradle of Sweden, this week. Loved it! Ancient buildings and monastery ruins are abundant here. We even had meals in the 13th century throne hall of King Valdemar!

1 in 3 patients with actinic keratosis will develop some type of skin cancer within 10 y, @guorgis showed in his PhD oral defence. Many thanks for inviting me as the faculty opponent, Prof Magnus Falk, Prof Chris Anderson. pubmed.ncbi.nlm.nih.gov/32314794/ doi:10.2340/00015555-3486

Great news for people with melanoma stage III - neo-adjuvant therapy new standard of care! nejm.org/doi/pdf/10.105…

Indeed, a very patient-centered PhD thesis on breast reconstruction👏, brilliantly defended by Jonas Löfstrand, Plastic Surgery, Sahlgrenska. Thanks 🙏 for inviting me to chair the examining board: supervisors Emma Hansson, Mattias Lidén, Victoria Fröjd. lnkd.in/dKR5Mgyk

Wow! So cool! Simply had to visit The Eagle pub while in Cambridge, 🇬🇧. This is where Watson & Crick celebrated in 1959 after having discovered the DNA structure! Rosalind Franklin (go girl! 💪) and Maurice Wilkins deserve credit too. 👌 As a researcher, I take a humble bow..